Key result
An enhanced single-strand conformation polymorphism method detected small dystrophin gene mutations in 73% of Duchenne dystrophy patients previously lacking identifiable mutations.
Why the study?
Does an enhanced method of single-strand conformation polymorphism analysis improve the detection of small mutations in patients with Duchenne dystrophy without identifiable gene mutations?
Cohort (n=93)
Does an enhanced method of single-strand conformation polymorphism analysis improve the detection of small mutations in patients with Duchenne dystrophy without identifiable gene mutations?
An enhanced single-strand conformation polymorphism method significantly increases the detection of small dystrophin gene mutations, supporting DNA analysis as the initial diagnostic test for suspected Duchenne dystrophy.
Answers are grounded in this paper and cite their sources.
May aid Duchenne dystrophy diagnosis via higher mutation detection; leaves open need for prospective validation before practice change.
OBJECTIVE: To determine whether detection of small mutations of the dystrophin gene can be increased using an enhanced method of single-strand conformation polymorphism analysis. BACKGROUND: Usual methods of DNA analysis for Duchenne dystrophy cannot identify mutations in one-third of cases. Muscle biopsy, with its inherent risks and added liability for patients with Duchenne dystrophy, becomes the sole method of diagnosis. Even with a tissue diagnosis of dystrophin deficiency, many families are excluded from carrier detection and prenatal diagnosis. METHODS: Genomic DNA from a cohort of 93 patients with Duchenne dystrophy without identifiable gene mutations was screened for mutations. In each case, 22 kilobases of genomic DNA were scanned, including all 79 exons of the dystrophin gene, adjacent intronic regions, and six alternative exons 1. RESULTS: Sixty-eight (73%) had small mutations, including 34 nonsense mutations, 27 microdeletions and insertions, and 7 splice site mutations. No missense mutations were found. One nonsense mutation in exon 59 was detected in four patients. Most mutations were new; 54 of 62 different small mutations have not been reported. Mutations were found throughout the gene: 24% in the first quartile, 31% in the second, 16% in the third, and 29% in the fourth. CONCLUSIONS: A highly sensitive single-strand conformation polymorphism method substantially increased detection of small dystrophin gene mutations and made it possible to diagnose approximately 90% of patients with Duchenne dystrophy by DNA analysis. These findings, combined with cost savings and safety issues, provide compelling reasons to consider DNA analysis as the initial diagnostic test for the suspected dystrophin-deficient patient.
No takes yet. Share an insight, caveat, or question.
Mendell et al. (2001) conducted a cohort in Duchenne dystrophy (n=93). Enhanced method of single-strand conformation polymorphism analysis vs. Usual methods of DNA analysis was evaluated on Detection of small mutations of the dystrophin gene. An enhanced single-strand conformation polymorphism method detected small dystrophin gene mutations in 73% of Duchenne dystrophy patients previously lacking identifiable mutations.
Synapse has enriched 10 related papers. Consider them for comparative context: